Disease Info Card

Thymus Neoplasms

Information about Thymus Neoplasms: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Thymus Neoplasms

Most recent studies have shown that Thymus Neoplasms shares some biological mechanisms with autoimmune-diseases, carcinoid-tumor, carcinoma, hyperplasia, invasive-thymoma, leukemia, lung-neoplasms, lymphoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, mediastinal-neoplasms, myasthenia-gravis, myasthenias, neoplasm-invasiveness, neoplasm-metastasis, neoplasm-of-uncertain-or-unknown-behavior-of-mediastinum, neoplasms, thymic-carcinoma, thymoma, thymus-hyperplasia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Thymus Neoplasms, and have been seen in publications frequently: Angiogenesis, Cell Cycle, Cell Death, Cell Development, Cell Differentiation, Cell Growth, Cell Maturation, Cell Proliferation, Dna Repair, Hormone Secretion, Immune Response, Localization, Methylation, Mismatch Repair, Oncogenesis, Pathogenesis, Programmed Cell Death, Secretion, V(d)j Recombination

Quite a number of genes have been found to play important roles in Thymus Neoplasms, such as BBS9, BCL2, CD4, CD5, CD8A, CTLA4, EGFR, HLA-DQA1, IL2, MS4A1, MYC, NOD2, PLEKHM1, POMC, SPANXB1, SST, TP53, TTN. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.